ivabradine mylan õhukese polümeerikattega tablett
mylan pharmaceuticals limited - ivabradiin - õhukese polümeerikattega tablett - 5mg 112tk; 5mg 100tk; 5mg 56tk; 5mg 98tk; 5mg 14tk
nutrineal pd4 clear-flex peritoneaaldialüüsilahus
oÜ baxter estonia - aminohapped+naatriumkloriid+kaltsiumkloriiddihüdraat+magneesiumkloriidheksahüdraat+naatriumlaktaat - peritoneaaldialüüsilahus - 11,2g+5,38g+0,184g+0,051g+4,48g 1l 2l 4tk
raploc infusioonilahuse pulber
amomed pharma gmbh - landiolool - infusioonilahuse pulber - 600mg 1tk
sarclisa
sanofi winthrop industrie - isatuximab - mitu müeloomit - antineoplastilised ained - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
abiraterone accord
accord healthcare s.l.u. - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopaatiline kopsufibroos - immunosupressandid - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - tsütomegaloviiruse infektsioonid - viirusevastased ravimid süsteemseks kasutamiseks - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). tuleks arvesse võtta ametlikke juhiseid sobiva kasutamise kohta viirusevastane ained.
pirfenidone accord õhukese polümeerikattega tablett
accord healthcare b.v. - pirfenidoon - õhukese polümeerikattega tablett - 267mg 168tk; 267mg 84tk; 267mg 63tk; 267mg 21tk
pirfenidone accord õhukese polümeerikattega tablett
accord healthcare b.v. - pirfenidoon - õhukese polümeerikattega tablett - 801mg 252tk
angiox
the medicines company uk ltd - bivalirudin - Äge koronaarsündroom - antitrombootilised ained - angiox on näidustatud on antikoagulant täiskasvanud patsientidel toimumas perkutaanse koronaarse interventsiooni (pci), sealhulgas patsiendid, kellel on st-segmendi-elevatsiooniga müokardiinfarkti (stemi) toimumas primaarne pci. angiox on näidustatud ka ravi täiskasvanud patsientidel, kellel ebastabiilne stenokardia / mitte-st-segmendi-elevatsiooniga müokardiinfarkti (ua / nstemi) planeeritud kiiresti või varajane sekkumine. angiox tuleb manustada koos aspiriini ja clopidogrel.